NCT07123987View on ClinicalTrials.gov

Transcutaneous Auricular Vagus Nerve Stimulation on Post-Herpetic Neuralgia

NARecruitingINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

January 1, 2026

Study Completion Date

March 1, 2026

Conditions
Post Herpetic Neuralgia (PHN)
Interventions
DEVICE

transcutaneous auricular vagus nerve stimulation (taVNS)

Use of the EV-906 device with TENS ear clips for transcutaneous auricular vagus nerve stimulation (taVNS), applied according to the study protocol, in addition to standard medical treatment for post-herpetic neuralgia. This device meets ISO 13485, FDA QSR, and CE standards

OTHER

traditional medical treatment for PHN

Standard medical treatment for post-herpetic neuralgia as per current clinical guidelines, without the application of taVNS device.

Trial Locations (1)

12613

RECRUITING

Faculty of Physical Therapy - Cairo University, Cairo

All Listed Sponsors
lead

Mohamed Hosny Ismail Easa

OTHER

NCT07123987 - Transcutaneous Auricular Vagus Nerve Stimulation on Post-Herpetic Neuralgia | Biotech Hunter | Biotech Hunter